09:47 AM EST - Appili Therapeutics Inc. : Announced the United States Patent and Trademark Office and the Mexican Patent Office have granted new patent claims protecting its oral formulation of metronidazole, LIKMEZ®™. Appili Therapeutics Inc.
shares T.APLI are trading unchanged at $0.03.
